These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16431379)

  • 1. Biopharmaceutical evaluation of oral tablet Atenolol (100 and 50 mg) on local population.
    Ali O; Obaid R; Saify ZS; Ahmed SW
    Pak J Pharm Sci; 2005 Jan; 18(1):25-32. PubMed ID: 16431379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination.
    Marzo A; Monti NC; Dal Bo L; Mazzucchelli P; Crivelli F; Tettamanti RA; Ismaili S; Uhr MR; Ronchi C; Porziotta E
    Arzneimittelforschung; 2000 Sep; 50(9):802-8. PubMed ID: 11050696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats.
    Jia J; Dong C; Zhang W; Cui Y; Liu J
    J Pharm Biomed Anal; 2011 May; 55(2):342-8. PubMed ID: 21353427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability study of two atenolol tablet preparations.
    Peh KK; Yuen KH; Wong JW; Toh WT
    Drug Dev Ind Pharm; 1999 Mar; 25(3):357-60. PubMed ID: 10071830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men.
    Wang XM; Yu XY; Lin SG
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):367-70. PubMed ID: 10452127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacological aspects of PK/PD modelling.
    Lemmer B
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):458-64. PubMed ID: 9352396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
    Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
    Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of atenolol.
    Vergin H; Nitsche V
    J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.